in

Canntab receives indication of patentability for its release cannabidiol formulation video



Canntab Therapeutics (CSE:PILL.CN-OTCQX: CTABF) Chief Financial Officer Richard Goldstein joined Steve Darling from Proactive Investors Vancouver on Skype with news that the company has received an initial assessment from the Geneva-based International Preliminary Report on Patentability regarding their Immediate Release Cannabidiol Formulation
Goldstein talks about what that means for the company going forward and how this fall will be a defining moment for the company.

Likes: .

This video clip was viewed: 1064 times and has a duration of 00:07:32 seconds.

What do you think?

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0

Comments

0 comments

Beth Chapman on her cancer battle, moving Da Kine Bail Bonds office

Beth Chapman on her cancer battle, moving Da Kine Bail Bonds office video

The Truth About Cancer documentary - Interview with Dr. Rath and Dr. Niedzwiecki

The Truth About Cancer documentary – Interview with Dr. Rath and Dr. Niedzwiecki video